Insular thyroid carcinoma in the background of follicular thyroid carcinoma: A report of a rare case and mini‑review of the literature

Introduction

Follicular thyroid carcinoma (FTC) is an uncommon well-differentiated malignant tumor accounting for 10% of all thyroid malignancies (1,2). It has been reported to be more common in African American populations than in Asians or Caucasians, with a female predominance (3). Insular thyroid carcinoma (ITC) is another thyroid malignancy that is even rarer, poorly differentiated and accounts for only 0.1 to 6.2% of all thyroid malignancies (4). Although ITC is rare, it represents the main cause of mortality from non-anaplastic follicular cell-derived thyroid cancer, and 20% of patients with ITC present with distant metastasis at the time of diagnosis (5). The observation of ITC arising within the background of FTC is an exceedingly unique occurrence (6).

The present study reports a case of ITC arising within the background of FTC, with a brief review of the literature.

Case report

Patient information

A 52-year-old housewife presented to Smart Health Tower (Sulaimani, Iraq) with anterior neck swelling for a duration of 6 months. She had a negative previous medical, surgical and drug history but a positive family history of thyroid diseases.

Clinical findings and diagnostic assessment

The patient had a grade 2 thyroid enlargement with a hard consistency. The hematological test results of the patient were normal. An ultrasound (US) examination (images not available) revealed a well-defined solid nodule measuring ~58x37x28 mm in the mid-lower third of the right thyroid lobe without micro or macro calcification, and with a TI-RADS 4 according to the Thyroid Imaging Reporting and Data System (TIRADS). Furthermore, two small nodules of <3 mm in size were also observed in the left thyroid lobe. Fine needle aspiration cytology of the lesion led to the suspicion of a follicular neoplasm, that fell into the Bethesda IV category.

Therapeutic intervention

Following a right thyroid lobectomy, the histopathological examination led to the diagnosis of ITC arising within follicular carcinoma (Fig. 1). Consequently, completion thyroidectomy was performed based on this diagnosis. The immunostaining of thyroid transcription factor 1 (TTF1) and PAX 8 were used to rule out medullary thyroid carcinoma due to the presence of multiple foci of spinning and large anaplastic cells, with bizarre giant cells. The patient was later sent for radioiodine ablation. Of note, as the patient was an outpatient, both the histological and immunohistochemistry examinations were conducted by an external laboratory (Shorsh Hospital Pathology Laboratory). For this reason, unfortunately, the authors could not retrieve the exact methodology of the aforementioned procedures.

Figure 1 (A) Section illustrating solid nests of follicular epithelial cells, exhibiting an insular pattern of arrangement (yellow arrows) with the presence of notable mitotic activities (black arrows) (magnification, x10; scale bar, 200 µm, hematoxylin and eosin staining). (B) Some of the cells are arranged as small micro follicles that filled with colloid material (yellow arrows) with mitotic activities (dark arrows) (magnification, x10; scale bar, 200 µm, hematoxylin and eosin staining).

Follow-up and outcome

The vital signs of the patient were stable, and levothyroxine substitution therapy was prescribed, commencing at 150 mcg daily for 1 year post-operatively, followed by a maintenance dose of 100 mcg daily. Following the definitive diagnosis and the decision of the multidisciplinary team of Smart Health Tower, the patient received two doses of radioactive iodine, with a one-year interval between doses. Following three years of follow-up, the patient was completely asymptomatic.

Discussion

The ITC is a rare and highly aggressive thyroid malignancy that is morphologically and biologically considered an intermediate between fully differentiated and undifferentiated/anaplastic thyroid carcinomas (7). In 1984, Carcangiu et al (8) described ITC for the first time as a poorly differentiated carcinoma. It is termed as insular as it is composed of well-defined nests. However, this pattern may be less prominent, and tubercular or solid patterns are recognized and co-exist (9).

The tumor has frequently been misdiagnosed and often grouped with solid or moderately differentiated tumors, and it has sometimes been mistaken for anaplastic carcinoma (10). In comparison to patients solely with FTC, patients with ITC are older, more often male, have larger tumor sizes, are more likely to experience metastasis, are less likely to have a negative resection margin, and have a significantly lower survival rate (11). Patients with ITC usually complain of the presence of a rapidly growing neck swelling in association with dyspnea, dysphagia and voice hoarseness (12). The case described in the present study was a 52-year-old female with a hard neck mass and normal vocal cords, with no other associated symptoms.

Histologically, ITC is characterized by small uniform carcinoma cells, small follicles containing thyroglobulin and necrotic foci, with a prospect of a peritheliomatous structure formation (10). The aforementioned characteristics were also observed in the histopathological analysis of the case described herein. Necrosis is another obvious finding, with both capsular and vascular invasion (13). However, Harach and Franssila (14) concluded in their study that even though ITC has thyroglobulin secretion, among 5 cases, 2 cases were negative for thyroglobulin. The molecular processes behind the unique insular structure found in thyroid tumors pose a challenge, impeding the comprehension of the factors contributing to their aggressive nature. Recently, research has turned to molecular analysis techniques, such as polymerase chain reaction-single-strand conformation polymorphism analysis, in hopes of unraveling these mechanisms. These efforts have revealed a spectrum of mutations associated with ITC (15). Notably, genetic alterations affecting genes, such as the RAS family (N-ras gene) and p53 gene have been documented (16). Additionally, in poorly differentiated thyroid carcinoma, TERT promoter mutations are frequently observed. Despite this, mutually exclusive mutations in BRAF and RAS remain the prevailing driver mutations in poorly differentiated thyroid carcinoma (17,18). Due to limited resources, genetic tests were not conducted for the case reported in the present study. Almost all stages of FTC are treated with total or near-total thyroidectomy, iodine ablation and thyroid hormone suppression therapy (19). Similarly, aggressive management is recommended for patients with ITC, and the most appropriate treatment is total thyroidectomy followed by radioiodine therapy and close follow-up. These were also performed for the patient described herein. According to the study by Pezzi et al (11), the primary treatment for almost all patients with ITC was surgery undertaken in ~98% of cases, while this number was 95% in FTC cases. A total thyroidectomy was performed for the majority of patients with ITC (79.6%), with a positive margin being found in 32.7% of the resected ITC cases (11). A re-operation for these cases is usually associated with the risk of nerve injury and post-operative hypocalcemia (20).

The ITC is highly aggressive with a high rate of recurrence and distant metastasis, ranging from 36 to 92% (10). The prognosis of patients with FTC is dependent on several factors, such as post-operative residual gross, age, local or distant metastasis, size of the tumor and the pathologic category (21). Even though the effect of ITC on the biological behavior of masses with follicular origin remains unknown (22), studies in the genuine literature (23) still demonstrate that the presence of ITC in fully differentiated FTC is associated with distant metastasis (7,24). Moreover, it has been reported that patients who have tumors with a minor insular component are not evidenced to have a poor prognosis (7).

In conclusion, poorly differentiated ITC emerging from the background of FTC is a very rare incidence that is more aggressive than any other thyroid tumor, and it is usually associated with distant metastasis. The management of choice for these cases is direct total thyroidectomy, followed by radioiodine therapy.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

AMS and ASM were major contributors to the conception of the study, as well as to the literature search for related studies. HOB, MNH and FHK were involved in the literature review, in the writing of the manuscript, and in the design of the study. AMA was the pathologist who performed the histopathological diagnosis. GLO, IJH, ROM, SHH and HMD were involved in the literature review, in the design of the study, in the critical revision of the manuscript and in the processing of the images. FHK and SHH confirm the authenticity of all the raw data. All authors have read and approved the final manuscript.

Ethics approval and consent to participate

Written informed consent was obtained from the patient for her participation in the present study.

Patient consent for publication

Written informed consent was obtained from the patient for the publication of the present case and any accompanying images.

Competing interests

The authors declare that they have no competing interests.

References